Related references
Note: Only part of the references are listed.Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities
Jinhyun Kim et al.
JOURNAL OF RHEUMATIC DISEASES (2021)
Characteristics of Post-traumatic-spondyloarthritis: A Cross-sectional Study From a Single Tertiary Hospital
Hong Ki Min et al.
JOURNAL OF RHEUMATIC DISEASES (2021)
Causal Association between Rheumatoid Arthritis with the Increased Risk of Type 2 Diabetes: A Mendelian Randomization Analysis
Young Ho Lee et al.
JOURNAL OF RHEUMATIC DISEASES (2019)
The current status and unmet needs in the management of psoriatic arthritis: Viewpoint from physicians in Taiwan
Tzu-Hao Li et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
Philip Mease et al.
LANCET (2018)
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
P. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Dafna Gladman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
L. Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis
Y. H. Lee et al.
LUPUS (2016)
Meta-Analysis of Genetic Association Studies
Young Ho Lee
ANNALS OF LABORATORY MEDICINE (2015)
Current Concepts in Psoriatic Arthritis: Pathogenesis and Management
Kurt De Vlam et al.
ACTA DERMATO-VENEREOLOGICA (2014)
Network meta-analysis for comparing treatment effects of multiple interventions: an introduction
Ferran Catala-Lopez et al.
RHEUMATOLOGY INTERNATIONAL (2014)
A Microsoft-Excel-based tool for running and critically appraising network meta-analyses-an overview and application of NetMetaXL
Stephen Brown et al.
SYSTEMATIC REVIEWS (2014)
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
L. Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Omega-3 Polyunsaturated Fatty Acids and the Treatment of Rheumatoid Arthritis: A Meta-analysis
Young-Ho Lee et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis
Gwan Gyu Song et al.
CLINICAL RHEUMATOLOGY (2012)
Associations between gene polymorphisms and rheumatoid arthritis: a meta-analysis
Young Ho Lee et al.
INFLAMMATION RESEARCH (2012)
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
J. P. T. Higgins et al.
RESEARCH SYNTHESIS METHODS (2012)
Automating network meta-analysis
Gert van Valkenhoef et al.
RESEARCH SYNTHESIS METHODS (2012)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
DD Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
PS Changelian et al.
SCIENCE (2003)
Share Paper
